FDA's ability to fulfill its mission to protect and promote public health depends almost entirely on its world-class workforce of talented, dedicated public servants.
Tim Kaine
The Public Record
Tim Kaine is a United States Senator from Virginia, serving since January 3, 2013. A member of the Democratic Party, he previously held the position of Governor of Virginia from January 14, 2006, to January 16, 2010. Kaine has been an advocate for various issues including education, healthcare, and military engagement, emphasizing the importance of Congress's role in declaring war and authorizing military force. He also served as the Chair of the Democratic National Committee, contributing to the party's strategy and outreach efforts during his tenure.
I also rise to discuss the Supreme Court nomination of Judge Neil Gorsuch of the Tenth Circuit. I take this very seriously. I started my legal career as an appellate law clerk in the Eleventh Circuit Court of Appeals in the South, working…
I thank my friend, the deputy majority leader, the senior Senator from Texas. I draw support for my conclusion about that language from two other cases that Judge Gorsuch was involved in in the Tenth Circuit, one case dealing with…
I would appreciate it. I will take 2 minutes and finish quickly. The PRESIDING OFFICER. The Senator from Virginia.
Let's be clear. Those tweaks alone will not solve the problem. More work is needed outside the FDA context and outside this committee's jurisdiction to address the root cause of high prices.
I would like to ask the other witnesses--Ms. Haycombe was asked about the potential effects of a $6 billion cut in NIH to medical innovation.
Partnership implies a shared goal, a shared set of values, and the United States and the European Union do have a shared goal of trying to confine Russian aggression.
The astronomical cost of prescription drugs is a financial hardship for so many patients and families and communities, and we need to face up to the tough questions.
I think 25 million to 30 million Americans, in total, are affected by rare diseases.
While drug pricing is outside of the FDA's jurisdiction and the most robust solutions likely involve HHS and CMS, this is something this committee needs to address this Congress.
I'd like to keep it that way, and I'm hopeful we can move beyond the failed Trumpcare proposal and work together to build on the progress we have made in our healthcare system.
If these nations see the United States or the administration, the current administration, being lackadaisical about Russian attacks...
Do you share her view that a budget cut of that magnitude to the NIH would be devastating to medical innovation?
Patients and families in my home State of Washington and nationwide deserve to know the devices used in their care are safe and effective, and I'm going to continue fighting for this until we get meaningful safeguards in place so we can…
One insurance commissioner told me that if we did not act by April of this year, there would not be insurance sold in his State next year, which is 2018.
It cleared out an obstacle that was an obstacle for a lot of the other nations.
I think Nikki Haley last night was laying out--I know that she is planning on significant reforms.
I do not think we did enough here today to really talk about what our core national interests are.
There was a lot of concern that some of the rhetoric from the President might have an effect on domestic Mexican politics and possibly increase the odds of a Chavez type leader being elected President of Mexico.
I think the time is right and I look forward to the discussion as the change of administration and new strategies are in place.
I think to an extent we can do everything we can both at the U.N. and at the State Department to make sure that everything we are doing matters.





